A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

1992 Nature 2,546 citations

Abstract

Interleukin-1 beta (IL-1 beta)-converting enzyme cleaves the IL-1 beta precursor to mature IL-1 beta, an important mediator of inflammation. The identification of the enzyme as a unique cysteine protease and the design of potent peptide aldehyde inhibitors are described. Purification and cloning of the complementary DNA indicates that IL-1 beta-converting enzyme is composed of two nonidentical subunits that are derived from a single proenzyme, possibly by autoproteolysis. Selective inhibition of the enzyme in human blood monocytes blocks production of mature IL-1 beta, indicating that it is a potential therapeutic target.

Keywords

EnzymeProteaseCysteineBETA (programming language)BiochemistryCysteine proteaseChemistryPeptideCloning (programming)Molecular biologyBiology

MeSH Terms

Amino Acid SequenceBase SequenceBindingCompetitiveCaspase 1ChromatographyAffinityChromatographyDEAE-CelluloseChromatographyHigh Pressure LiquidChromosome MappingCloningMolecularDiazomethaneElectrophoresisPolyacrylamide GelHumansInterleukin-1MetalloendopeptidasesMolecular Sequence DataMonocytesOpen Reading FramesProtein ProcessingPost-TranslationalSequence HomologyNucleic AcidSubstrate Specificity

Affiliated Institutions

Related Publications

Publication Info

Year
1992
Type
article
Volume
356
Issue
6372
Pages
768-774
Citations
2546
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

2546
OpenAlex
98
Influential
2102
CrossRef

Cite This

Nancy A. Thornberry, Herbert G. Bull, Jimmy Calaycay et al. (1992). A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes. Nature , 356 (6372) , 768-774. https://doi.org/10.1038/356768a0

Identifiers

DOI
10.1038/356768a0
PMID
1574116

Data Quality

Data completeness: 81%